The New York Times, one of the influential media outlets of the US media, wrote that the US officials regarding Johnson & Johnson’s single-dose Covid-19 vaccine were preparing to call for a break in the vaccine.
In the report, it was stated that six women who received the vaccine developed a blood clot problem, and it was underlined that this was a rare event.
‘FDA AND CDC APPROVED STOP PLAN’
It was reported that the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA), the two most important health institutions in the USA, confirmed the plan to stop the vaccine in their statements.
In the news, it was stated that the CDC will hold a Vaccination Practices Advisory Committee (ACIP) meeting on Wednesday to examine the current cases in more detail and evaluate their potential importance, while the FDA will review the analysis while investigating these cases.
‘WE RECOMMEND STOPING THE VACCINE’
In addition, it was stated that the US Food and Drug Administration (FDA) used the expressions “We recommend that the use of this vaccine be stopped very carefully until this process is completed”.
In the 62-page review of the US Food and Drug Administration (FDA), published in late February, Johnson & Johnson’s single-dose Covid-19 vaccine was effective and safe.
INVESTIGATION IN EUROPE
Recently, the European Medicines Agency (EMA) launched an investigation after the corona virus (Covid-19) vaccine developed by the US-based Johnson & Johnson pharmaceutical company was observed in 4 people who had blood clotting side effects.